Stay updated on Bepirovirsen in Chronic Hepatitis B Clinical Trial
Sign up to get notified when there's something new on the Bepirovirsen in Chronic Hepatitis B Clinical Trial page.

Latest updates to the Bepirovirsen in Chronic Hepatitis B Clinical Trial page
- ChecktodayChange DetectedRecruitment status updated from Active, not recruiting to Completed. New Chinese sites were added with updated postal codes Hangzhou 310022, Liuzhou 545006, and Shenzhen 518112, while outdated site entries were removed.SummaryDifference0.3%

- Check7 days agoChange DetectedA new trial site has been added in Liuzhou, China, and Liuchow, China has been removed from the Locations list.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page revision/version is updated from **v3.5.2** to **v3.5.3**, indicating a system or site software update rather than any change to the study information.SummaryDifference0.0%

- Check29 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

- Check36 days agoChange DetectedPadua, Italy, 35128 was replaced with Padova, Italy, 35128 in the study locations, with Padova added and Padua removed.SummaryDifference0.0%

- Check50 days agoChange DetectedThe study location entry was updated from Napoli, Italy, 80131 to Naples, Italy, 80131.SummaryDifference0.0%

Stay in the know with updates to Bepirovirsen in Chronic Hepatitis B Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bepirovirsen in Chronic Hepatitis B Clinical Trial page.